Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 09, 2022

SELL
$2.72 - $5.72 $798,469 - $1.68 Million
-293,555 Closed
0 $0
Q2 2021

Aug 10, 2021

SELL
$2.32 - $5.38 $1.16 Million - $2.69 Million
-500,000 Reduced 63.01%
293,555 $1.43 Million
Q4 2020

May 12, 2021

BUY
$1.32 - $2.74 $1.05 Million - $2.17 Million
793,555 New
793,555 $2.17 Million

Others Institutions Holding CLSD

About Clearside Biomedical, Inc.


  • Ticker CLSD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,190,700
  • Market Cap $56M
  • Description
  • Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...
More about CLSD
Track This Portfolio

Track Aju Ib Investment Co., Ltd. Portfolio

Follow Aju Ib Investment Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aju Ib Investment Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Aju Ib Investment Co., Ltd. with notifications on news.